SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.86
−4.62%Margins
Gross margin
-252.4%
EBITDA margin
-445.7%
EBIT margin
-563.9%
Net margin
-177.0%
FCF margin
-504.2%
-22.5%
Return on equity
-15.4%
Return on assets
-55.0%
Return on invested capital
0.09x
Asset turnover
-$7.4M
Cash from operations
$4.04
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026